Syneos Health Expands AI Ecosystem With Three New Platform Partnerships - Applied Clinical Trials Online
Syneos Health has partnered with three new AI platforms to enhance its clinical trial ecosystem, aiming to improve efficiency and data analysis.
- Syneos Health has formed three new AI platform partnerships to strengthen its clinical trial ecosystem.
- The partnerships aim to improve efficiency in drug development through advanced data analytics and automation.
- The move reflects the broader industry trend of integrating AI into clinical research to accelerate timelines and reduce costs.
- Specific platform names were not disclosed, but the focus is on tools for large-scale data processing and real-time analytics.
Syneos Health, a global contract research organization, has expanded its AI ecosystem by forming partnerships with three new platforms. These collaborations focus on enhancing clinical trial operations through advanced data analytics, automation, and predictive modeling. The move aligns with the growing demand for AI-driven solutions in drug development, particularly in streamlining patient recruitment, monitoring, and regulatory compliance.
The partnerships were announced as part of Syneos Health's broader strategy to integrate AI into its clinical research services. While specific platform names were not disclosed in the announcement, the focus appears to be on tools that can handle large-scale data processing, real-time analytics, and adaptive trial designs. This expansion could position Syneos Health as a leader in AI-enabled clinical research, competing with other major players in the contract research space.
Opportunities to build or integrate AI tools for clinical trial applications.
Enhanced efficiency and cost savings in drug development through AI-driven solutions.
Potential growth in the contract research sector due to AI adoption.
AI is increasingly shaping the future of clinical trials and healthcare innovation.
- Contract Research Organization (CRO)
- A company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.
Young adults in the U.S. are increasingly wary of AI, concerned it will take jobs - Pew Research Center
EdgeRunner and U.S. Army Artificial Intelligence Integration Center Collaborate to Build Army-Specific LLM - businesswire.com
BusinessOpenAI launches a safer ChatGPT for teens — years after teens started using it
Duke partners with Anthropic, offering “pay-as-you-go” Claude subscriptions - The Duke Chronicle
Edgerunner AI CEO Tyler Saltsman on developing military artificial intelligence - foxbusiness.com
FundingEtched’s valuation doubles to $21B in a month
Etched’s valuation surged to $21 billion after Jane Street deployed its AI cluster and led a new funding round. The startup claims the deployment impressed the trading firm enough to double its valuation in weeks.
Hampton University opens AI center to expand access to emerging technology - 13newsnow.com
Hampton University opened a new AI center to provide students with hands-on training and resources in artificial intelligence.
When AI art has no author: Study finds generated images often can’t be traced to training data - MIT News
A new study from MIT finds that AI-generated images often cannot be reliably traced back to specific images within their training datasets, posing challenges for copyright and data attribution.
Artificial intelligence or clever artifice? - Chemistry World
A new study in Chemistry World questions whether AI truly advances chemistry or merely mimics existing knowledge without real innovation.
AI ToolsWarp’s new system is an out-of-the-box software factory for AI development
Warp unveiled Warp Factories, a new infrastructure system that simplifies the creation of AI software factories for developers.
AI ToolsI let an AI agent write to my database. 11 of 17 records diverged from what I asked for.
A developer found that an AI agent miswrote 11 out of 17 database records when tasked with simple customer data entry.